Capecitabine and Oxaliplatin in Combination as First- Or Second-Line Therapy for Metastatic Breast Cancer: A Wisconsin Oncology Network Trial
Cancer Chemotherapy and Pharmacology - Germany
doi 10.1007/s00280-012-2044-2
Full Text
Open PDFAbstract
Available in full text
Date
December 11, 2012
Authors
Publisher
Springer Science and Business Media LLC